St. Luke's Hospital - Quakertown Campus — Quakertown, Pennsylvania

St. Luke's Hospital - Quakertown Campus is a clinical research site located in Quakertown, Pennsylvania, United States 18951.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

St. Luke's Hospital - Quakertown Campus has participated in 3 clinical trials.

Therapeutic areas: Early Breast Cancer, BRAF or NRAS Mutant Metastatic Melanoma, Metastatic or Unresectable Cutaneous Melanoma.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Hospital - Quakertown Campus?

St. Luke's Hospital - Quakertown Campus has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Hospital - Quakertown Campus conducted?

St. Luke's Hospital - Quakertown Campus has 3 clinical trials on record. Their work covers Early Breast Cancer, BRAF or NRAS Mutant Metastatic Melanoma, Metastatic or Unresectable Cutaneous Melanoma.

Is St. Luke's Hospital - Quakertown Campus accredited by Crixeo Health?

St. Luke's Hospital - Quakertown Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Hospital - Quakertown Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.